New Horizon Health Limited (HK:6606) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
New Horizon Health Limited, a biotech firm specializing in cancer screening products in China, reports that its business operations remain stable despite the ongoing suspension of its stock trading. The company continues to work towards resuming trading, following guidance from the Hong Kong Stock Exchange. Investors are advised to stay informed as the company makes further announcements on its progress.
For further insights into HK:6606 stock, check out TipRanks’ Stock Analysis page.